Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Centrifuged autologous fat (CAF) is a biological tissue graft prepared by harvesting adipose tissue from a patient—typically via liposuction from the abdomen, thighs, or gluteal region—and processing it through centrifugation. This mechanical separation removes blood, lipids, and anesthetic contaminants, resulting in a concentrated suspension of viable adipocytes and adipose-derived regenerative cells (ADRCs). CAF is utilized in regenerative medicine and plastic surgery as an injectable filler to treat conditions such as glottic insufficiency (vocal fold paralysis), soft tissue defects, and to prevent complications like capsular contracture in breast augmentation. The centrifugation step is a key technical variation intended to improve the predictability and longevity of the fat graft compared to non-centrifuged alternatives.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on centrifuged autologous fat.